Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations

M Liu, D Svirskis, T Proft, J Loh, S Chen, D Kang… - International journal of …, 2022 - Elsevier
The oral delivery of medicines is the most popular route of administration for patients.
However, thymopentin (TP5) is only available in the market in forms for parenteral …
被引用次数：5 相关文章

Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations.

M Liu, D Svirskis, T Proft, J Loh, S Chen, D Kang… - 2022 - researchspace.auckland.ac.nz
The oral delivery of medicines is the most popular route of administration for patients.
However, thymopentin (TP5) is only available in the market in forms for parenteral …

Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations.

M Liu, D Svirskis, T Proft, J Loh, S Chen… - International Journal …, 2022 - europepmc.org
The oral delivery of medicines is the most popular route of administration for patients.
However, thymopentin (TP5) is only available in the market in forms for parenteral …

Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations

M Liu, D Svirskis, T Proft, J Loh… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
The oral delivery of medicines is the most popular route of administration for patients.
However, thymopentin (TP5) is only available in the market in forms for parenteral …